145 related articles for article (PubMed ID: 25687047)
21. [Tumor lysis syndrome].
Hagino T
Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
[TBL] [Abstract][Full Text] [Related]
22. Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries.
Annemans L; Moeremans K; Lamotte M; Garcia Conde J; van den Berg H; Myint H; Pieters R; Uyttebroeck A
Leuk Lymphoma; 2003 Jan; 44(1):77-83. PubMed ID: 12691145
[TBL] [Abstract][Full Text] [Related]
23. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
24. Daily serum phosphate increase as early and reliable indicator of kidney injury in children with leukemia and lymphoma developing tumor lysis syndrome.
Biró E; Erdélyi D; Varga P; Sinkó M; Bartyik K; Kovács G; Ottóffy G; Vincze F; Szegedi I; Kiss C; Szabó T
Pediatr Nephrol; 2023 Sep; 38(9):3117-3127. PubMed ID: 36943467
[TBL] [Abstract][Full Text] [Related]
25. Tumor lysis syndrome in small cell carcinoma and other solid tumors.
Kalemkerian GP; Darwish B; Varterasian ML
Am J Med; 1997 Nov; 103(5):363-7. PubMed ID: 9375703
[TBL] [Abstract][Full Text] [Related]
26. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.
Razis E; Arlin ZA; Ahmed T; Feldman EJ; Puccio C; Cook P; Chun HG; Helson L; Mittelman A
Acta Haematol; 1994; 91(4):171-4. PubMed ID: 7976113
[TBL] [Abstract][Full Text] [Related]
27. Rasburicase for the management of tumor lysis syndrome in neonates.
McNutt DM; Holdsworth MT; Wong C; Hanrahan JD; Winter SS
Ann Pharmacother; 2006; 40(7-8):1445-50. PubMed ID: 16868218
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
[TBL] [Abstract][Full Text] [Related]
29. How we treat tumor lysis syndrome.
Muslimani A; Chisti MM; Wills S; Nadeau L; Zakalik D; Daw H; Huang J; Jaiyesimi I
Oncology (Williston Park); 2011 Apr; 25(4):369-75. PubMed ID: 21618960
[TBL] [Abstract][Full Text] [Related]
30. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.
Lopez-Olivo MA; Pratt G; Palla SL; Salahudeen A
Am J Kidney Dis; 2013 Sep; 62(3):481-92. PubMed ID: 23684124
[TBL] [Abstract][Full Text] [Related]
31. Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia.
Sevinir B; Demirkaya M; Baytan B; Güneş AM
Turk J Haematol; 2011 Mar; 28(1):52-9. PubMed ID: 27263942
[TBL] [Abstract][Full Text] [Related]
32. Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy.
Suzuki T; Takeuchi M; Saeki H; Yamazaki S; Koga H; Abe D; Nishimura M; Nakaseko C; Nakasa H; Nakamura H; Ariyoshi N; Kitada M
Clin Ther; 2010 Mar; 32(3):527-31. PubMed ID: 20399989
[TBL] [Abstract][Full Text] [Related]
33. [An exceptionally severe hyperuricemia in acute renal failure caused by spontaneous tumor lysis syndrome (TLS)].
Basile C; Montanaro A
G Ital Nefrol; 2003; 20(5):525-8. PubMed ID: 14634969
[TBL] [Abstract][Full Text] [Related]
34. [Incidence and Risk Assessment of Tumor Lysis Syndrome in Patients with Advanced Germ Cell Cancer].
Kurobe M; Kawai K; Tanaka K; Ichioka D; Yoshino T; Kandori S; Kawahara T; Waku N; Takaoka E; Kojima T; Joraku A; Suetomi T; Miyazaki J; Nishiyama H
Hinyokika Kiyo; 2016 May; 62(5):237-42. PubMed ID: 27320114
[TBL] [Abstract][Full Text] [Related]
35. [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
Kikuchi T; Miyata A; Fujii S; Kikuchi T
Rinsho Ketsueki; 2003 Nov; 44(11):1113-6. PubMed ID: 14689878
[TBL] [Abstract][Full Text] [Related]
36. Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.
Vines AN; Shanholtz CB; Thompson JL
Ann Pharmacother; 2010 Oct; 44(10):1529-37. PubMed ID: 20841516
[TBL] [Abstract][Full Text] [Related]
37. Carfilzomib-associated tumor lysis syndrome.
Shely RN; Ratliff PD
Pharmacotherapy; 2014 May; 34(5):e34-7. PubMed ID: 24390940
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome.
Knoebel RW; Lo M; Crank CW
J Oncol Pharm Pract; 2011 Sep; 17(3):147-54. PubMed ID: 20332174
[TBL] [Abstract][Full Text] [Related]
39. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
Darmon M; Vincent F; Camous L; Canet E; Bonmati C; Braun T; Caillot D; Cornillon J; Dimicoli S; Etienne A; Galicier L; Garnier A; Girault S; Hunault-Berger M; Marolleau JP; Moreau P; Raffoux E; Recher C; Thiebaud A; Thieblemont C; Azoulay E;
Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
[TBL] [Abstract][Full Text] [Related]
40. Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: a case series and literature review.
Chiang J; Chan A; Lian T; Tay K; Quek R; Tao M; Lim ST
Asia Pac J Clin Oncol; 2011 Dec; 7(4):351-6. PubMed ID: 22151984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]